Sorry, you need to enable JavaScript to visit this website.
  1. Home
  3. Science
  4. Clinical Trials
  5. Plain Language Study Results Summaries
  6. Study Use Modified Rna Vaccine

Study on Use of a Modified RNA Vaccine for Influenza in Healthy Participants

 A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza in Healthy Individuals

Category & Conditions: Vaccine-related Conditions
Medicine: PF-07252220
ClinicalTrials.gov Identifier (NCT): NCT05052697
Protocol ID: C4781001
DownloadPrint

Open Plain Language Summary Result:

Click here